News Center

Home page

Peak Report

News reports

Pro 2014-014 (Jianfeng Group's 2013 Annual Shareholders' Meeting)

Release time:

2020-08-05

Stock Abbreviations: Jianfeng Group Stock Code: 600 66 8 No: pro 20 14 -0 14

Zhejiang Jianfeng Group Co., Ltd.

2013 Annual General Meeting Resolution Announcement

The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .

Important Content Note:

1 , No Rejection or Modification of Proposals at this Meeting;

2 , no new proposal submitted for vote at this meeting.

1. Meeting and Attendance

The 2013 Annual Shareholders' Meeting of (I) Zhejiang Jianfeng Group Co., Ltd. was held at 9: 00 a.m. on June 6, 20 14 at Jianfeng Building, 88 Wujiang East Road, Jinhua City, Zhejiang Province by on-site voting.

(II) The shareholders and proxies present at the meeting are shown in the following table:

Number of shareholders and agents attending the meeting	9
Total number of voting shares (shares)	57617437
the proportion of to the total voting shares of the company (%)	16.75

(III) The notice of this meeting was published in china securities journal and Shanghai Securities News on April 15, 109 20 14. The meeting was convened by the board of directors of the company and presided over by Mr. Jiang Xiaomeng, chairman of the board of directors. The voting method of the meeting complied with the "Company Law" and the "Articles of Association.

(IV) that the company has 8 current directors. Chairman Jiang Xiaomeng, directors Du Zihong, Yu Jianhong and independent director Zhang Yuyou attended the meeting. Other directors failed to attend the meeting due to work reasons. The company has 5 current supervisors, including supervisors Qin Xuping, Chen Chunhui and Yuan Jie, who attended the meeting. Other supervisors failed to attend the meeting due to work reasons. Zhu Jianwei, secretary of the board of the company, attended the meeting; some of the company's executives attended the meeting.

2. Proposal Review

This meeting deliberated and passed the following proposals by secret ballot and item by item:

1, 2013 Board of Directors Work Report;

number of valid voting shares	number of shares	number of shares	number of shares	number of shares	abstention number of shares	Abstention Ratio	Pass
57617437	57617437	100%	0	0	0	0	passed

2 and 2013 work reports of the board of supervisors;

number of valid voting shares	number of shares	number of shares	number of shares	number of shares	abstention number of shares	waiver ratio	whether to pass
57617437	57617437	100%	0	0	0	0	passed

3 and 2013 financial final accounts report;

number of valid voting shares	number of shares	number of shares	number of shares	number of shares	abstention number of shares	waiver ratio	whether to pass
57617437	57617437	100%	0	0	0	0	passed

4 and 2013 profit distribution plans;

number of valid voting shares

number of shares

abstention number of shares

waiver ratio

whether it has passed

More information

Monitoring Report of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project

2020

07-30

Monitoring Report of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project

2020

07-31

Monitoring Report of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project

2020

07-31

Daye Jianfeng Cement Co., Ltd. Kiln End Flue Gas Desulfurization Project Completion Environmental Protection Acceptance Publicity

Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution

2020

07-31

Spike New Drug Approved for Registration

On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)

2020

07-31

Spike New Drug Approved for Registration

2020

07-31

< 1...30 31 32...61 > 跳转到页